Related Experiment Video
Updated: Feb 5, 2026

Induction and Diverse Assessment Indicators of Experimental Autoimmune Encephalomyelitis
Published on: September 9, 2022
Early P2X7R-dependent activation of microglia during the asymptomatic phase of autoimmune encephalomyelitis
Tomasz Grygorowicz1, Lidia Strużyńska2
1Laboratory of Pathoneurochemistry, Department of Neurochemistry, Mossakowski Medical Research Centre, Polish Academy of Sciences, 5 Pawińskiego str., 02-106, Warsaw, Poland.
Abstract:
Microglia-mediated neuroinflammation accompanies many central nervous system (CNS) diseases, including multiple sclerosis (MS), and is strongly dependent on the purinergic P2X7 receptor. The nature of the inflammatory response in MS is studied for decades indicating, that proinflammatory microgliosis is involved in advanced stages of MS and is associated with active tissue damage and neurological dysfunctions. Evidence on the role of microgliosis in initial stages of the disease is scarce. Thus, in the present study, we investigated the time course of microglial activation in rat brain subjected to experimental autoimmune encephalomyelitis (EAE) which is the animal model of MS. We show that activation of microglia occurs in brains of immunized rats at a very early stage of EAE, well before the development of neurological symptoms of the disease. Enhanced immunoreactivity of microglia/macrophage-specific protein Iba-1, together with morphological features of microgliosis, was identified beginning at day 4 post immunization. Concomitantly, microglial expression of P2X7R was also examined. Moreover, our results reveal that administration of Brilliant Blue G, an antagonist of P2X7R, delays the onset of the disease and partially inhibits development of neurological symptoms in EAE rats. Blockage of P2X7R significantly reduces activation of microglia as confirmed by decreased Iba-1 immunoreactivity and suppresses neuroinflammation in EAE rat brains, as indicated by decreased protein levels of investigated proinflammatory cytokines: IL-1β, IL-6 and TNF-α. Our results indicate that microglia are involved in inducing neuroinflammation at a very early stage of MS/EAE via a P2X7R-dependent mechanism.
Insights
Microglia activation and neuroinflammation occur early in experimental autoimmune encephalomyelitis (EAE), the animal model for multiple sclerosis (MS). Blocking the P2X7 receptor reduces this early inflammation and delays disease symptoms.
Area of Science:
- Neuroscience
- Immunology
- Pathology
Background:
- Microglia-mediated neuroinflammation is central to central nervous system (CNS) diseases like multiple sclerosis (MS).
- The purinergic P2X7 receptor (P2X7R) plays a critical role in this inflammatory response.
- While microgliosis is known in advanced MS, its role in early disease stages is less understood.
Purpose of the Study:
- To investigate the temporal dynamics of microglial activation in the early stages of experimental autoimmune encephalomyelitis (EAE), an animal model for MS.
- To examine the role of the purinergic P2X7 receptor (P2X7R) in early microglial activation and neuroinflammation during EAE.
- To evaluate the therapeutic potential of P2X7R antagonism in mitigating EAE progression.
Main Methods:
- Induction of EAE in rats as an animal model for MS.
- Assessment of microglial activation using Iba-1 immunoreactivity and morphological analysis at various time points post-immunization.
- Measurement of P2X7R expression in microglia.
- Administration of Brilliant Blue G, a P2X7R antagonist, to assess its effects on disease onset, neurological symptoms, and neuroinflammation.
- Quantification of proinflammatory cytokines (IL-1β, IL-6, TNF-α) in brain tissue.
Main Results:
- Microglial activation, indicated by increased Iba-1 immunoreactivity and morphological changes, was observed as early as day 4 post-immunization, preceding neurological symptom development.
- P2X7R expression was concurrently upregulated in activated microglia.
- Treatment with Brilliant Blue G delayed EAE onset, partially ameliorated neurological deficits, and significantly reduced microglial activation and neuroinflammation.
- P2X7R blockade led to decreased levels of IL-1β, IL-6, and TNF-α in the EAE rat brains.
Conclusions:
- Microglia are activated and contribute to neuroinflammation at a very early stage of EAE/MS.
- This early neuroinflammation is dependent on the purinergic P2X7 receptor (P2X7R) pathway.
- Targeting P2X7R represents a potential therapeutic strategy to intervene in the early inflammatory processes of MS.
More Related Videos
08:47Induction of Experimental Autoimmune Encephalomyelitis in Mice and Evaluation of the Disease-dependent Distribution of Immune Cells in Various Tissues
Published on: May 8, 2016
05:44A Rapid, Simple, and Standardized Homogenization Method to Prepare Antigen/Adjuvant Emulsions for Inducing Experimental Autoimmune Encephalomyelitis
Published on: December 9, 2022
Related Concept Videos
Phase Diagrams
Phase Transitions
Autoimmune Disorders
Concept and Mechanism of Autoimmune Diseases
The immune...
Frequency-dependent Selection
Temperature Dependence on Reaction Rate
Atoms, molecules, or ions must collide before they can react with each other. Atoms must be close together to form chemical bonds. This premise is the basis for a theory that explains many observations regarding chemical kinetics, including factors affecting reaction rates.
The collision theory is based on the postulates that (i) the reaction rate is proportional to the rate of reactant collisions, (ii) the reacting species collide in an orientation allowing contact between...
Conservative Site-specific Recombination and Phase Variation
The recognition sites for Cre recombinase called LoxP...